Viewing Study NCT03211195


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-02-02 @ 6:56 PM
Study NCT ID: NCT03211195
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2017-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sotagliflozin Bioequivalence Study
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module